๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials USA
Clinical trial register · United States · industry-sponsored

Industry-sponsored studies with a US investigative site

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors โ€” the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice โ€” all 9110 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 22 Sep 2026, 03:16 UTC
9110
Studies in scope
industry-sponsored, all four open statuses
4947
Recruiting now
open to new participants
2198
Lead sponsors
across recruiting studies
Top states
California 5292 Florida 4393 Illinois 2478 Georgia 2343 Arizona 2230
Narrow the register
Recruitment status
Phase
Target enrolment
to
9110 of 9110 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
By invitation
Blood Donation Study for ALPCO Syphilis-T and Syphilis-NT Assay Development
NCT07830550Healthy Volunteers, Syphilis Serologic Assay Development, Blood Specimen Collection, Diagnostic Assay Development
American Laboratory Products Company
Observational
50
New Hampshire
2026-10
Not yet open
A Study Examining Acceptability of Auditory Implant Fitting Software Technologies
NCT07763873Hearing Impairment
Cochlear
Not applicable
200
Colorado
2026-10
Recruiting
FT839 in Autoimmune Diseases
NCT07800871ANCA-Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE)
Fate Therapeutics
Phase 1/2
446
California
2026-10
Not yet open
Evaluation of NWRD09 for Female Participants With Persistent HPV16 Infection
NCT07536282Persistent HPV16 Infection
Newish Biotech (Wuxi) Co., Ltd.
Phase 1/2
78
New York
2026-10
Not yet open
ProGo Menopause Wellbeing Study
NCT07611305Menopause Related Conditions
Hofseth Biocare ASA
Not applicable
100
California
2026-10
Not yet open
Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy
NCT07750678Hereditary Corneal Dystrophy, Corneal Abnormality, Corneal Dystrophies, Corneal Dystrophies, Hereditary
GenEditBio Limited
Phase 1/2
30
California
2026-10
Not yet open
Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults
NCT07531043Ocular Hyperemia
Alcon Research
Phase 3
230
Texas
2026-10
Not yet open
RENEW: Study of Porcine Liver Support in Participants With Acute-on-Chronic Liver Failure
NCT07429838Acute on Chronic Liver Failure (ACLF), Hepatic Encephalopathy (HE)
eGenesis, INC
Phase 1/2
20
Missouri, Wisconsin
2026-10
Not yet open
BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease
NCT07729995Rheumatoid Arthritis (RA), Systemic Lupus Erthematosus (SLE), Dermatomyositis (DM), Systemic Sclerosis (SSc)
Luminary Therapeutics
Phase 1
94
Massachusetts
2026-10
Not yet open
Knee Cartilage Repair Registry
NCT07786207Knee Injuries, Joint Surface Knee Lesions
Smith & Nephew, Inc.
Observational
1,000
District of Columbia, Indiana, Oklahoma
2026-09-30
Recruiting
A Study of Amicidin-ฮฒ Topical Solution for Patients With Surgical or Traumatic Wound Infections
NCT07379684Surgical Wound Infection, Traumatic Wound Infection
Macro Biologics, Inc.
Phase 1
44
California, Idaho, Maryland, Missouri, Ohio
2026-09-30
Not yet open
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
NCT07680790Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Phase 3
850
California, Colorado, Florida, Hawaii, Illinois, Maryland, Minnesota, Missouri
2026-09-30
Recruiting
Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])
NCT07831824Prostate Cancer
Lantheus Medical Imaging
Phase 2/3
408
Michigan
2026-09-30
Recruiting
Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML
NCT07723703Acute Myeloid Leukaemia, High Risk Myelodysplastic Syndrome
Amphista Therapeutics Ltd
Phase 1
54
Virginia
2026-09-30
Not yet open
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
NCT07808151Colon Cancer, Microsatellite Stable (MSS) Colon Cancer, Proficient Mismatch Repair (pMMR) Colon Cancer
Solstice Oncology, Inc.
Phase 2
100
California, Florida, Illinois, Maryland, Massachusetts, New York, Ohio, Tennessee
2026-09-30
Recruiting
To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
NCT06840496Rett Syndrome
Biomed Industries, Inc.
Phase 3
210
Arizona, California, Colorado, Florida, Illinois, Maryland, Massachusetts, New York
2026-09-30
Not yet open
An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)
NCT07807969Geographic Atrophy
Annexon, Inc.
Phase 3
605
Florida, Maryland, Massachusetts, North Carolina, Oregon
2026-09-30
Not yet open
A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
NCT07725796Bladder (Urothelial, Transitional Cell) Cancer, NMIBC, Urothelial Carcinoma Bladder, Urothelial Carcinoma in Situ
UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
Phase 1
30
Arizona, California, Massachusetts, Nebraska, New York, Pennsylvania, South Carolina, Texas
2026-09-30
Not yet open
Study to Evaluate Xtressรฉ Gummy Supplement in Men With Androgenic Alopecia
NCT07637071Androgenic Alopecia, Hair Loss/Baldness, Hair Thinning
Restore Biologics Holdings, Inc. dba Xtressรฉ
Not applicable
48
Florida
2026-09-29
Not yet open
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07816666Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer, Platinum-sensitive Relapsed Primary Peritoneal Cancer
AstraZeneca
Phase 3
600
Alaska, Maryland, Michigan, New York, Ohio, Pennsylvania, West Virginia
2026-09-29
Not yet open
DAREONยฎ-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
NCT07707895Small Cell Lung Cancer, Large Cell Neuroendocrine Lung Carcinoma, Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology, Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
Boehringer Ingelheim
Phase 1/2
60
District of Columbia, Florida, Illinois, Kentucky
2026-09-29
Not yet open
Evaluation of the F&P Licorice Mask, US, 2026
NCT07826429Chronic Respiratory Conditions, Obstructive Sleep Apnea (OSA)
Fisher and Paykel Healthcare
Not applicable
45
Missouri
2026-09-28
Not yet open
A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord Injury
NCT07799532Chronic Spinal Cord Injury
NervGen Pharma
Phase 3
150
Alabama, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Maryland
2026-09-23
Not yet open
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
NCT07668414Overweight, Obesity
Novo Nordisk A/S
Phase 3
650
California, District of Columbia, Florida, Georgia, Illinois, Indiana, Louisiana, Missouri
2026-09-22
Not yet open
A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease
NCT07250815Ulcerative Colitis, Crohn's Disease
Takeda
Observational
23,900
Massachusetts
2026-09-21
Not yet open
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
NCT07768189Oropharyngeal Carcinoma (OPC)
Corbus Pharmaceuticals Inc.
Phase 3
260
Arizona, California, Colorado, Connecticut, Florida, Illinois, Iowa, Maryland
2026-09-20
Not yet open
A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy
NCT07723963Juvenile Myoclonic Epilepsy
Jazz Pharmaceuticals
Phase 2/3
260
Arizona, Connecticut, Florida, Georgia, Hawaii, Idaho, Louisiana, Michigan
2026-09-18
Recruiting
The Effects of Quercefitยฎ and Ubiqsomeโ„ข in Mitigating Inflammation and Promoting Metabolic Health
NCT07760506Healthy Aging, Inflammaging, Metabolic Health, Quercetin
Applied Science & Performance Institute
Not applicable
60
Florida
2026-09-18
Recruiting
A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)
NCT07734610Severe Renal Impairment, Healthy
Merck Sharp & Dohme LLC
Phase 1
20
Florida
2026-09-17
Not yet open
A Study to See How Safe a New Medicine (NNC0642-1895) is in Healthy People
NCT07829406Healthy Volunteers
Novo Nordisk A/S
Phase 1
148
Utah
2026-09-17
Not yet open
Radicle HealthTM VIP: A Study Assessing the Impact of Health and Wellness Products on Metabolic Health and Related Health Outcomes
NCT07819110Metabolic Health
Radicle Science
Not applicable
220
California
2026-09-17
Recruiting
A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
NCT07793409Chronic Obstructive Pulmonary Disease
Sanofi
Phase 3
1,508
California, Florida
2026-09-16
Not yet open
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
NCT07817251Diabetes Mellitus, Type 2
Novo Nordisk A/S
Phase 3
210
Arizona, California, Connecticut, Florida, Hawaii, Illinois, Iowa, Kansas
2026-09-16
Not yet open
A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female Participants
NCT07777133Healthy Female Participants
Bristol-Myers Squibb
Phase 1
6
Wisconsin
2026-09-16
Recruiting
A Study to Test the AdaptDx Pro Agreement in Rod Intercept Time With the AdaptDx in Healthy Subjects With Normal Vision (FlashBack)
NCT07803588Healthy Adult Participants
AdaptDx, Inc.
Observational
24
California
2026-09-15
Not yet open
Healthy Person Eats, Takes 1 Dose, Tested for Drowsiness, Fall Risk, Then Takes Second Dose Followed by Same Tests
NCT07801066Healthy Participants
Primus Pharmaceuticals
Phase 4
20
Ohio
2026-09-15
Recruiting
Transverse Tibial Bone Transport (TTT) in the Management of Chronic Diabetic Lower Extremity Wounds
NCT07444593Diabetic Foot Ulcer, Chronic Ulcers of the Lower Limb
Biodynamik, Inc
Not applicable
100
Florida
2026-09-15
By invitation
TruVascular Access - Ultrasound-Guided Vascular Access Study
NCT07798427Peripheral Venous Catheterization, Difficult Intravenous Access, Catheterization, Peripheral
Truway Health, Inc.
Not applicable
250
New York
2026-09-15
Recruiting
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
NCT07648264Secondary Immune Deficiency
CSL Behring
Phase 3
63
California, Colorado, Florida, Indiana, Maryland, New Jersey, New York, North Carolina
2026-09-15
Recruiting
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
NCT07412704Arthritis, Rheumatoid
Bristol-Myers Squibb
Phase 1/2
84
California, Colorado, Florida, New York, Oregon, Pennsylvania, Texas
2026-09-15
Not yet open
Enamel Lesion Detection With New DX Tool
NCT07819370Enamel Lesions, Caries
Colgate Palmolive
Phase 4
5
Georgia
2026-09-15
Recruiting
A Pilot Study of Ultra-High Dose Rate (ConformalFLASHยฎ), for Reirradiation of Carcinoma of the Head and Neck
NCT07644585Head and Neck Cancer
IBA Proton Therapy, Inc.
Not applicable
10
Pennsylvania
2026-09-14
Not yet open
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
NCT07807345Head & Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer, Esophageal Cancer, Gastric Cancer
Sutro Biopharma, Inc.
Phase 1
285
California, Florida, Massachusetts, Oklahoma, Texas, Virginia
2026-09-14
Recruiting
Appetite and Cognition Response to a Breakfast Cereal
NCT07782229Cognition
General Mills
Not applicable
184
Minnesota
2026-09-14
Recruiting
A Clinical Investigation of a Topical Moisturizer on Skin Barrier Function in Adults With Sensitive Skin
NCT07811531Sensitive Skin
Good Molecules, LLC
Phase 4
24
New York
2026-09-14
Not yet open
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
NCT07540988Interstitial Lung Diseases
Boehringer Ingelheim
Phase 3
466
Alabama, California, Connecticut, Florida, Indiana, Kansas, Michigan, Minnesota
2026-09-14
Recruiting
Effects of Continuous Yogurt Intake on Immunomodulatory Function and Subjective Health Status in Healthy U.S. Adults
NCT07799207Immune Function
Meiji Co., Ltd.
Not applicable
118
Illinois
2026-09-14
Recruiting
ATR 1072 in Participants With PRKAG2 Syndrome
NCT07738107Cardiac Glycogenosis, Cardiomyopathy, Hypertrophic, Wolff-Parkinson-White Syndrome
Atrium Therapeutics
Phase 1/2
37
Missouri
2026-09-14
By invitation
RNS System for Drug-Resistant Focal Epilepsy in Adolescents: A Real-World Study
NCT07823465Focal Epilepsy, Drug-resistant Focal Epilepsy
NeuroPace
Observational
100
Massachusetts
2026-09-14
Recruiting
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
NCT07811193Colorectal Adenocarcinoma
Vividion Therapeutics, Inc.
Phase 2
140
Arizona, Michigan, West Virginia
2026-09-11
Not yet open
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism
NCT07284745Irritability Associated With Autism Spectrum Disorder
Bristol-Myers Squibb
Phase 3
176
Alabama, Arizona, California, Colorado, Florida, Georgia, Illinois, Kentucky
2026-09-11
Not yet open
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder
NCT07285798Irritability Associated With Autism Spectrum Disorder
Bristol-Myers Squibb
Phase 3
176
Arizona, California, Connecticut, Florida, Georgia, Illinois, Massachusetts, Missouri
2026-09-11
Recruiting
A Study of AWT020 in Participants With Advanced Solid Tumors
NCT07822919Advanced Cancers (Solid Tumors)
Anwita Biosciences
Phase 1
96
Florida
2026-09-11
Recruiting
Clinical Outcomes of 3D Printed and Milled Complete Dentures
NCT07586774Edentulous Mouth, Edentulous Jaw
Dentsply Sirona Implants and Consumables
Not applicable
68
North Carolina
2026-09-11
Recruiting
A Study in Adults With Geographic Atrophy
NCT07606365Geographic Atrophy
Sitala Bio LTD
Phase 2
300
California, Colorado, Connecticut, Illinois, Maryland, Massachusetts, New York, Pennsylvania
2026-09-11
Recruiting
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
NCT07543055Prostate Cancer
Regeneron Pharmaceuticals
Phase 1
36
New Jersey, Oregon
2026-09-10
Not yet open
Evaluation of Approved Contact Lenses (CR-6657)
NCT07819305Visual Acuity
Johnson & Johnson Vision Care, Inc.
Not applicable
150
Florida, Illinois, New York, Ohio, Tennessee, Texas, Virginia
2026-09-10
Not yet open
Multi-strain Probiotic Supplement for Digestive Comfort and Well-being in Healthy Women
NCT07831317Gastrointestinal Discomfort, Bloating
Daily Nouri
Not applicable
160
California
2026-09-10
Not yet open
Non-invasive Saphenous Nerve Stimulation Therapy for Overactive Bladder
NCT07780786Overactive Bladder (OAB)
NinaMED Pty Ltd
Phase 3
290
New Jersey
2026-09-10
Recruiting
A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
NCT07815665Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma (UC)
Summit Therapeutics
Phase 2/3
800
Arizona, California, District of Columbia, Florida, Minnesota, Tennessee, Washington
2026-09-10
Recruiting
A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
NCT07775924Cutaneous Lichen Planus
Novartis Pharmaceuticals
Phase 2
259
Alabama, California, Florida, Georgia, Indiana, Louisiana, Michigan
2026-09-10
Recruiting
Safety and Tolerability of an Ultra Absorbency Menstrual Tampon Compared to a Commercially Marketed Tampon
NCT07807891Safety and Tolerability in Healthy Volunteers
Lyv Life Inc. (dba: Cora)
Not applicable
120
Florida
2026-09-10
Recruiting
Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC
NCT07813637Prostate Cancer, Castration-Resistant Prostate Cancer (CRPC), Metastatic Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer Patients
Janux Therapeutics
Phase 1
110
Tennessee
2026-09-10
Recruiting
Clinical Performance of AH Plus Jetยฎ Root Canal Sealers in Single-cone Protocols
NCT07642284Root Canal Treatment
Dentsply Sirona Implants and Consumables
Not applicable
130
New York
2026-09-09
Not yet open
A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults
NCT07819097Adult, Healthy Participants
Pfizer
Phase 3
600
Connecticut, Ohio, Pennsylvania, Utah, Virginia
2026-09-09
Recruiting
Device for Treating Generalized Anxiety
NCT07819773Generalized Anxiety Disorder (GAD)
BTL Industries Ltd.
Not applicable
40
Colorado, Illinois, Indiana
2026-09-09
Recruiting
A Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB)
NCT07640984Mucopolysaccharidosis IIIB
JCR Pharmaceuticals Co., Ltd.
Phase 1/2
12
California, Pennsylvania, Virginia
2026-09-09
Recruiting
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
NCT07416552Metastatic Colorectal Cancer
Hoffmann-La Roche
Phase 1
180
Nebraska, Texas, Wisconsin
2026-09-08
Recruiting
Safety and Effectiveness of Mosaic for the Treatment of Midface Volume Deficit
NCT07710443Midface Volume Deficit
Helios Aesthetics Inc.
Not applicable
50
Florida, Massachusetts, New York, Pennsylvania
2026-09-08
Recruiting
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
NCT06357377Pediatric Tumor of CNS, Pediatric Tumor of Brain, Diffuse Midline Glioma, H3 K27M-Mutant, Pediatric Tumor of Brain Stem
Neonc Technologies, Inc.
Phase 1
12
California
2026-09-08
Recruiting
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
NCT07226206Hemophilia A
Hoffmann-La Roche
Phase 1/2
5
California
2026-09-08
Recruiting
A Phase 1 Dose-escalation and Expansion Study of In Vivo BCMA-CAR T Cell Therapy (VV169) in Patients With Relapsed or Refractory Multiple Myeloma
NCT07802717Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Vyriad, Inc.
Phase 1
40
Minnesota
2026-09-08
Not yet open
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
NCT07793929End Stage Renal Disease, Renal Impairment, Obesity, Overweight
Kailera
Phase 1
32
Texas
2026-09-08
Not yet open
A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults
NCT07794748Pneumococcal Disease
Pfizer
Phase 3
4,670
California, Connecticut, Florida, Georgia, Hawaii, Illinois, Iowa, Michigan
2026-09-08
Recruiting
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
NCT07623200Essential Thrombocythemia
Incyte Corporation
Phase 3
426
Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois, Kansas
2026-09-08
Not yet open
A Trial of Inebilizumab in Participants With Autoimmune Hepatitis
NCT07598825Autoimmune Hepatitis, AIH
Amgen
Phase 3
180
Arkansas, California, Indiana, Texas
2026-09-07
Recruiting
Effects of P24 on Postprandial Aminoacidemia
NCT07479173Postprandial Amino Acid Concentrations in Healthy Adults
Amplifye
Not applicable
30
California
2026-09-05
Recruiting
The Effects of Tyrosol and Creatine on Exercise Performance and Cognition in Healthy Adults
NCT07756658Tyrosol, Creatine, Endurance Performance, Cognition
Applied Science & Performance Institute
Not applicable
60
Florida
2026-09-04
Recruiting
A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)
NCT07807865Generalized Anxiety Disorder
Intra-Cellular Therapies, Inc.
Phase 3
900
California
2026-09-03
Recruiting
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease
NCT07764146Alzheimer s Disease
Voyager Therapeutics
Phase 1
18
Florida
2026-09-03
Recruiting
Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers
NCT07681076Healthy Volunteers
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 4
225
California, Florida, Georgia
2026-09-03
By invitation
Multimodal Physiologic State Intelligence Study
NCT07814118Heart Failure, Cardiomyopathies, Pulmonary Hypertension, Myocarditis; Acute or Subacute
Truway Health, Inc.
Observational
25,000
New York
2026-09-02
Recruiting
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
NCT07730021Locally Advanced or Metastatic Solid Tumors
Astellas Pharma Global Development, Inc.
Phase 1/2
392
New York, Virginia
2026-09-02
Recruiting
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
NCT07609719Multiple Sclerosis
Genentech, Inc.
Phase 4
100
Georgia, Tennessee
2026-09-02
Recruiting
MBA Early Feasibility Study
NCT07564375Thoracic Aortic Aneurysm, Penetrating Aortic Ulcers (PAUs), Thoracic Aortic Dissection, Pseudoaneurysm
W.L.Gore & Associates
Not applicable
20
California, Texas
2026-09-02
Recruiting
A Study on the Efficacy of a Vaccine Against Influenza in Adults โ‰ฅ65 Years of Age
NCT07805707Influenza, Human
GlaxoSmithKline
Phase 3
54,000
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia
2026-09-02
Recruiting
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
NCT07623161Myelofibrosis, Anemia
Takeda
Phase 3
324
Arizona, California, District of Columbia, Florida, Georgia, Massachusetts, Missouri, Montana
2026-09-02
Not yet open
A Comparison of Cosmos Rx Medication Adherence Platform vs. Pharmacy Fill Adherence Measures
NCT07712614GERD (Gastroesophageal Reflux Disease)
Cosmos Rx, Inc
Not applicable
50
Maryland
2026-09-01
Not yet open
2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients
NCT06432166Alzheimer Disease, Mild Cognitive Impairment
MTI Biotech Inc
Phase 1/2
48
Tennessee
2026-09-01
Not yet open
Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited Retinal Degeneration (LCA-IRD)
NCT07681778Leber Congenital Amaurosis, Leber Congenital Amaurosis (LCA)
Opus Genetics, Inc
Phase 1/2
10
Arizona, Pennsylvania, Texas
2026-09-01
Not yet open
Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections
NCT05750589Retinal Disease
iRenix Medical, Inc.
Phase 3
240
Texas
2026-09-01
Not yet open
Open Label, Multi-Center Study, Evaluating the Effect of Adipose Tissue Processed With the SyntrFugeโ„ข System for Facial Fat Grafting
NCT05522426Facial Atrophy and Loss of Contour
Syntr Health Technologies, Inc.
Not applicable
50
California
2026-09-01
Not yet open
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
NCT07691970Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus
AstraZeneca
Phase 3
1,072
California, Florida, Illinois, Michigan, New York, South Carolina
2026-09-01
Not yet open
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
NCT07720271Overweight, Obesity
Novo Nordisk A/S
Phase 3
950
Alabama, California, Colorado, Florida, Georgia, Hawaii, Illinois, Indiana
2026-09-01
Rows per page Showing 101–200 of 9110
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-usa?page=2

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.